Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1506-1517
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1506
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1506
Figure 1 The relative expression of neutrophil gelatinase-associated lipocalin was consistent with the content of pro-gastrin-releasing peptide in serum.
A: The relative gene expression of neutrophil gelatinase-associated lipocalin in serum in normal and six samples of tubular adenocarcinoma of the colon (P1 to P6); B: The content of pro-gastrin-releasing peptide (pg/mL) in serum. Three independent experiments were carried out and analyzed. Data are expressed as mean values ± SE, bP < 0.01, two-tailed Student’s t-tests. NGAL: Neutrophil gelatinase-associated lipocalin; pro-GRP: Pro-gastrin-releasing peptide.
- Citation: Yuan JH, Xie LS, Zhu YH, Wang XH, Zhang YJ, Wang XJ. Combination of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 are biomarkers for the detection of colon tubular adenocarcinoma . World J Gastrointest Oncol 2021; 13(10): 1506-1517
- URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1506.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1506